Portfolio company
Mantis Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops predictive models of human physiology and behaviour to provide digital twins for medical and human performance industries.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Elem
This company develops digital twin platforms that simulate human organs and physiology to conduct virtual clinical trials for pharmaceutical and medical device organisations.
Virtonomy
This company provides a software platform for creating digital patient twins to simulate medical device performance for medical technology manufacturers.
iOrganBio
This company develops an artificial intelligence-guided manufacturing platform to produce engineered human cells and organoids for biopharmaceutical researchers and clinical partners.
MedLea
This digital health company develops a digital twin platform to support diagnosis and prognosis of cardiorespiratory disorders for personalised medicine patients.
Deeplife
This company develops a cellular digital twin platform using artificial intelligence and multi-omics data to accelerate drug discovery for biotechnology and pharmaceutical researchers.
CueZen
This company develops a digital twin platform for health systems and governments to provide personalised interventions for population health management.
BioCorteX
This digital medicine company develops a simulation platform to model drug-microbiome interactions for pharmaceutical and biotechnology clients to improve treatment outcomes.
Tolemy Bio
This company develops an AI platform to model and optimise cellular behaviour for biotechnology and pharmaceutical organisations developing advanced therapies.